Andrade, Nadja S.
Ramic, Melina
Esanov, Rustam
Liu, Wenjun
Rybin, Mathew J.
Gaidosh, Gabriel
Abdallah, Abbas
Del’Olio, Samuel
Huff, Tyler C.
Chee, Nancy T.
Anatha, Sadhana
Gendron, Tania F.
Wahlestedt, Claes
Zhang, Yanbin
Benatar, Michael
Mueller, Christian
Zeier, Zane
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (R21 NS102829)
U.S. Department of Defense (AL160057)
National Institutes of Health (U54 NS090291, R01 NS088689)
Article History
Received: 17 July 2019
Accepted: 13 February 2020
First Online: 24 February 2020
Ethics approval and consent to participate
: Induced pluripotent stem cells were derived from the blood of consenting individuals within our C9ORF2-ALS patient population under IRB approved protocols at the University of Miami Miller School of Medicine.
: Not Applicable.
: The authors declare that they have no competing interests.